The Bio Report
Levine Media Group
The Bio Report podcast, hosted by award-winning journalist Daniel Levine, focuses on the intersection of biotechnology with business, science, and policy.
Get every episode summarized
Each time The Bio Report publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Episodes (1239)
Using Tumor Gene Therapy to Overcome Barriers to Immunotherapies
The Bio Report
Using AI to Generate Mini-Protein Therapeutics
The Bio Report
Inhibiting Cell Death to Preserve Vision in Retinal Diseases
The Bio Report
Leveraging Generative AI to Design Therapeutic Antibodies
The Bio Report
Managing Pain without Addiction
The Bio Report
Using AI to Match Cancer Patients to their Best Treatment Options
The Bio Report
A Venture Capitalist’s View of the Current Biotech Landscape
The Bio Report
Realizing the Therapeutic Potential of Cytokines by Making them Context Dependen...
The Bio Report
Targeting Cancer and Autoimmune Conditions with Donor-Derived EBV T Cells
The Bio Report
Reprogramming the Tumor Microenviroment to Activate an Immune Response
The Bio Report
Making Safer and More Effective Vaccines with Targeted mRNA
The Bio Report
Addressing a Global Need with RNA Vaccines and Immunotherapies
The Bio Report
Targeting Bacteria in Chronic Diseases
The Bio Report
Targeting Solid Tumors with Off-The-Shelf CAR T Therapies
The Bio Report
Reimagining the Development of Immunotherapies with a Venture Studio
The Bio Report
Repairing the Body with Advanced Cell Therapies
The Bio Report
Achieving Precision with AI Pathology
The Bio Report
Inducing Potent and Durable T Cell Responses to Fight Disease
The Bio Report
Developing Immunotherapies that Target the Drivers of Cancer
The Bio Report
Using Phase 0 Trials to Bring Precision Medicine to Treating Brain Tumors
The Bio Report
Restoring Feeling and Function to Damaged Nerves
The Bio Report
Enlisting Vaccines in the Fight Against Chronic Diseases
The Bio Report
Extending the Reach of Protein Degradation Therapies
The Bio Report
Growing the Bioeconomy
The Bio Report
Developing Targeted Therapies to Address Resistance in Cancer
The Bio Report
It Takes a Village
The Bio Report
Bringing Stick-to-itiveness to Regenerative Medicine
The Bio Report
A Biopharma Downturn or Return to Trend
The Bio Report
Treating Aging-Related Disease by Targeting Molecular Drivers of Aging
The Bio Report
Engineering Better Cell Therapies for Cancers
The Bio Report
Targeting a Regulator of Inflammation to Treat Alzheimer’s Disease
The Bio Report
Enabling Regenerative Therapies without Immunosuppression
The Bio Report
Making Vaccine and Biotherapeutic Production Fast and Affordable
The Bio Report
Forcing Cancers to Reveal Themselves
The Bio Report
Making Clinical Trials Diverse and Accessible
The Bio Report
Mining Bugs for Drugs
The Bio Report
A Company That Bets Its Therapies Will Click with Patients
The Bio Report
A Company Where It takes Guts and Brains to Develop Drugs
The Bio Report
Changing Outcomes with Data
The Bio Report
Treating Psychiatric Conditions with Tripless Psychedelics
The Bio Report
How AI Is Finding Its Way into Unexpected Places in Biopharma Companies
The Bio Report
Searching the Dark Matter of the Proteome to Develop New Therapies
The Bio Report
The Year in Biotech and What’s Ahead in 2023
The Bio Report
Targeting a Novel Checkpoint to Treat Cancer and Autoimmune Conditions
The Bio Report
The Growing Need for Biosecurity Vigilance
The Bio Report
Enlisting Next-Generation Cytokine Immunotherapies in the Fight Against Cancer
The Bio Report
Engineering Safer and More Effective Cell Therapies
The Bio Report
Changing Drug Discovery for Neuropsychiatric Disorders with Phenotypic Screens
The Bio Report
Using Virtual Reality-Guided Mindfulness to Treat Chronic Pain in Cancer Patient...
The Bio Report
Activating the Adaptive and Innate Immune Systems to Fight Cancer
The Bio Report